2023 annual financial data
Harmony Biosciences Holdings 2023 Operating cash flow growth
Direct answer
Operating cash flow growth was 51.86%.
Operating income was 192,030,000 USD and net income was 128,853,000 USD.
Operating cash flow was 219,387,000 USD.
Get free Harmony Biosciences Holdings email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 582,022,000 USD
- Operating income
- 192,030,000 USD
- Net income
- 128,853,000 USD
- Operating cash flow
- 219,387,000 USD